Literature DB >> 11298582

Dendritic cells and immunotherapy for malignant disease.

D C Reid1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11298582     DOI： 10.1046/j.1365-2141.2001.02626.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  13 in total

1.  In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.

Authors:  R V Goddard; A G Prentice; J A Copplestone; E R Kaminski
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

2.  Enhanced cytotoxicity of IL-24 gene-modified dendritic cells co-cultured with cytokine-induced killer cells to hepatocellular carcinoma cells.

Authors:  Xin Yu; Wei Xia; Tao Zhang; Hongwei Wang; Yufeng Xie; Jicheng Yang; Jingcheng Miao
Journal:  Int J Hematol       Date:  2010-08-11       Impact factor: 2.490

Review 3.  Immune cells in the tumour: new routes of retinoids for chemoprevention and chemotherapeutics.

Authors:  Li Jiang; Rong Dong; Meidan Ying; Qiaojun He; Ji Cao; Bo Yang
Journal:  Br J Pharmacol       Date:  2018-11-08       Impact factor: 8.739

4.  Optimization and limitation of calcium ionophore to generate DCs from acute myeloid leukemic cells.

Authors:  Thanh-Nhan Nguyen Pham; Bo-Hwa Choi; Hyun-Kyu Kang; Chun-Chi Jin; Nguyen Hoang Tuyet Minh; Sang-Ki Kim; Jong-Hee Nam; Deok-Hwan Yang; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Ik-Joo Chung; Je-Jung Lee
Journal:  Cancer Res Treat       Date:  2007-12-31       Impact factor: 4.679

5.  Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Breast Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes against Breast Cancer.

Authors:  Min-Ho Park; Deok-Hwan Yang; Mi-Hyun Kim; Jae-Hong Jang; Yoon-Young Jang; Youn-Kyung Lee; Chun-Ji Jin; Than Nhan Nguyen Pham; Truc Anh Nguyen Thi; Mi-Seon Lim; Hyun-Ju Lee; Cheol Yi Hong; Jung-Han Yoon; Je-Jung Lee
Journal:  Cancer Res Treat       Date:  2011-03-31       Impact factor: 4.679

Review 6.  Immunotherapy using dendritic cells against multiple myeloma: how to improve?

Authors:  Thanh-Nhan Nguyen-Pham; Yoon-Kyung Lee; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Clin Dev Immunol       Date:  2012-03-15

7.  Cellular immunotherapy using dendritic cells against multiple myeloma.

Authors:  Thanh-Nhan Nguyen-Pham; Youn-Kyung Lee; Hyun-Ju Lee; Mi-Hyun Kim; Deok-Hwan Yang; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Korean J Hematol       Date:  2012-03-28

8.  An immunohistochemical study of CD83- and CD1a-positive dendritic cells in the decidua of women with recurrent spontaneous abortion.

Authors:  Zhi-Da Qian; Li-Li Huang; Xiao-Ming Zhu
Journal:  Eur J Med Res       Date:  2015-01-07       Impact factor: 2.175

9.  Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.

Authors:  Manh-Cuong Vo; Hyun-Ju Lee; Jong-Seok Kim; My-Dung Hoang; Nu-Ri Choi; Joon Haeng Rhee; Vinoth-Kumar Lakshmanan; Sung-Jae Shin; Je-Jung Lee
Journal:  Oncotarget       Date:  2015-10-20

10.  Chaetocin enhances dendritic cell function via the induction of heat shock protein and cancer testis antigens in myeloma cells.

Authors:  Manh-Cuong Vo; Thanh-Nhan Nguyen-Pham; Hyun-Ju Lee; Sung-Hoon Jung; Nu-Ri Choi; My-Dung Hoang; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Oncotarget       Date:  2017-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.